Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

See more here:
New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Scroll to Top